SCHEMBL11058

SCHEMBL11058

CC[C@H](C)[C@H](NC(=O)OC)C(=O)NN(Cc1ccc(-c2ccccn2)cc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OC)C(C)C

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGT1A1 P22309 3/20 0.73
MLNR O43193 1/20 0.73
NR1I2 O75469 1/20 0.73
SLCO2B1 O94956 1/20 0.73
ABCB11 O95342 1/20 0.73
ABCB1 P08183 1/20 0.73
CCKAR P32238 1/20 0.73
OPRK1 P41145 1/20 0.73
GHSR Q92847 1/20 0.73
SLCO1B3 Q9NPD5 1/20 0.73
ABCG2 Q9UNQ0 1/20 0.73
SLCO1B1 Q9Y6L6 1/20 0.73
KCNH2 Q12809 1/20 0.56
CTSD P07339 5/20 0.47
CTSE P14091 1/20 0.47
PGC P20142 1/20 0.47
BACE1 P56817 1/20 0.44
CYP3A4 P08684 1/20 0.44
CA2 P00918 2/20 0.43
REN P00797 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6302 1.00 UGT1A1 (0.73) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL3552166 0.95 UGT1A1 (0.70) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL3552162 0.95 UGT1A1 (0.70) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6444 0.93 UGT1A1 (0.73) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6157343 0.92 UGT1A1 (0.62) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL7044 0.92 UGT1A1 (0.62) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6897 0.92 UGT1A1 (0.70) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL3548743 0.92 UGT1A1 (0.76) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL3548749 0.92 UGT1A1 (0.76) UGT1A1MLNRNR1I2SLCO2B1ABCB11
SCHEMBL6253 0.90 UGT1A1 (0.91) UGT1A1MLNRNR1I2SLCO2B1ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0900210-B1 ANTIVIRALLY ACTIVE HETEROCYCLIC AZAHEXANE DERIVATIVES NOVARTIS AG (CH) 2005-02-09 EP disclosed
US-6166004-A Combinations of HIV protease inhibitors with reverse transcriptase inhibitors NOVARTIS FINANCE CORPORATION (US) 2000-12-26 US disclosed
US-6110946-A AN ENZYME INHIBITORS OF RETROVIRAL ASPARTATE PROTEASE FOR THE TREATMENT OF AIDS NOVARTIS FINANCE CORPORATION (US) 2000-08-29 US disclosed
US-5849911-A Antivirally active heterocyclic azahexane derivatives NOVARTIS FINANCE CORPORATION (US) 1998-12-15 US disclosed